- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Snapshot for Medicure Inc (NGQ1)
| Open: | 0.156 | Day's Range: | 0.156 - 0.156 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.153 | 52wk Range: | 0.015 - 0.600 | 1-Yr Rtn: | +940.00% |
Key Statistics for NGQ1
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NGQ1
Company Profile & Key Executives for NGQ1
Medicure Inc. is a cardiovascular drug discovery and development company focused on developing therapeutics for unmet needs in the field of cardiovascular medicine. The Company's current focus is on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.
| Albert D FriesenChairman/CEO/Founder | Dawson J ReimerPresident/COO |
| James F KinleyCFO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NGQ1 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page